Abselion Appoints Dale Gordon as Chair 23 Mar Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous Bristol spin-out Albotherm awarded its first UK patent Next Next Monument Therapeutics Announces First Patient Dosed in Clinical Trial of MT1988 in Patients at Clinical High Risk for Psychosis
Abselion Appoints Dale Gordon as Chair 23 Mar Written by Alexandra Collingbourne Alexandra Collingbourne